$SODI
SOLITRON DEVICES INC Stock $sodi

$sodi Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-K Financial Statement

#000165495423008351 Filed on June 23, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2023
Revenue	$2.038M	$1.499M	$6.406M
YoY Change	-4.59%	-24.14%	-47.85%
Cost Of Revenue	$1.431M	$1.295M	$5.005M
YoY Change	8.49%	-30.26%	-33.13%
Gross Profit	$607.0K	$204.0K	$1.401M
YoY Change	-25.7%	71.43%	-70.81%
Gross Profit Margin	29.78%	13.61%	21.87%
Selling, General & Admin	$542.0K	$517.0K	$2.052M
YoY Change	-5.9%	-18.84%	-18.15%
% of Gross Profit	89.29%	253.43%	146.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$123.0K	$130.0K	$363.0M
YoY Change	75.71%	83.1%	137400.0%
% of Gross Profit	20.26%	63.73%	25910.06%
Operating Expenses	$542.0K	$517.0K	$2.052M
YoY Change	-5.9%	-18.84%	-18.15%
Operating Profit	$65.00K	-$313.0K	-$651.0K
YoY Change	-73.03%	-39.58%	-128.4%
Interest Expense	-$236.0K	$539.0K	$108.0K
YoY Change	-942.86%	-1383.33%	4.85%
% of Operating Profit	-363.08%
Other Income/Expense, Net	$0.00	$6.000K	$0.00
YoY Change	-100.0%	-94.06%	-100.0%
Pretax Income	-$171.0K	$232.0K	$826.0M
YoY Change	-122.18%	-150.54%	-76.45%
Income Tax	$0.00		$0.00
% Of Pretax Income			0.0%
Net Earnings	-$171.0K	$232.0K	$826.0K
YoY Change	-122.18%	-150.54%	-76.45%
Net Earnings / Revenue	-8.39%	15.48%	12.89%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.08	$0.11	$0.40
COMMON SHARES
Basic Shares Outstanding	2.083M shares	2.083M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q2	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.066M	$3.342M	$4.328M
YoY Change	-20.35%	-29.97%	-9.3%
Cash & Equivalents	$1.595M	$1.447M	$1.447M
Short-Term Investments	$2.471M	$1.895M	$2.881M
Other Short-Term Assets	$320.0K	$203.0K	$203.0K
YoY Change	4.58%	3.57%	3.57%
Inventory	$2.275M	$2.415M	$2.415M
Prepaid Expenses
Receivables	$1.191M	$784.0K	$784.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.852M	$7.730M	$7.730M
YoY Change	-11.46%	-12.35%	-12.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.249M	$7.360M	$7.360M
YoY Change	45.1%	49.41%	32.97%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.00K	$14.00K	$14.00K
YoY Change	250.0%	250.0%	250.0%
Total Long-Term Assets	$7.263M	$7.374M	$7.374M
YoY Change	8.58%	33.13%	33.13%
TOTAL ASSETS
Total Short-Term Assets	$7.852M	$7.730M	$7.730M
Total Long-Term Assets	$7.263M	$7.374M	$7.374M
Total Assets	$15.12M	$15.10M	$15.10M
YoY Change	-2.84%	5.2%	5.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$266.0K	$141.0K	$141.0K
YoY Change	-54.14%	4.44%	4.44%
Accrued Expenses	$904.0K	$907.0K	$857.0K
YoY Change	0.56%	2.14%	-1.72%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$109.0K	$110.0K	$110.0K
YoY Change	-3.54%	-1.79%	-1.79%
Total Short-Term Liabilities	$1.399M	$1.189M	$1.189M
YoY Change	-13.43%	2.59%	2.59%
LONG-TERM LIABILITIES
Long-Term Debt	$2.620M	$2.648M	$2.648M
YoY Change	-3.96%	-3.88%	-3.99%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$2.620M	$2.648M	$2.648M
YoY Change	-3.96%	-3.88%	-3.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.399M	$1.189M	$1.189M
Total Long-Term Liabilities	$2.620M	$2.648M	$2.648M
Total Liabilities	$4.019M	$3.837M	$3.837M
YoY Change	-7.5%	-2.04%	-2.04%
SHAREHOLDERS EQUITY
Retained Earnings	$10.65M	$10.82M
YoY Change	-1.08%	8.26%
Common Stock	$21.00K	$1.855M
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.412M	$1.412M
YoY Change	0.0%	0.0%
Treasury Stock Shares	487.8K shares	487.8K shares
Shareholders Equity	$11.10M	$11.27M	$11.27M
YoY Change
Total Liabilities & Shareholders Equity	$15.12M	$15.10M	$15.10M
YoY Change	-2.84%	5.2%	5.2%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$171.0K	$232.0K	$826.0K
YoY Change	-122.18%	-150.54%	-76.45%
Depreciation, Depletion And Amortization	$123.0K	$130.0K	$363.0M
YoY Change	75.71%	83.1%	137400.0%
Cash From Operating Activities	-$7.000K	-$652.0K	$953.0K
YoY Change	-100.43%	462.07%	-71.42%
INVESTING ACTIVITIES
Capital Expenditures	$12.00K	$42.00K	$2.188M
YoY Change	-91.43%	-105.6%	-55.26%
Acquisitions	$0.00		$0.00
YoY Change
Other Investing Activities	$194.0K	$1.550M	-$1.303M
YoY Change	-207.78%	-678.36%	234.1%
Cash From Investing Activities	$182.0K	$1.508M	-$3.491M
YoY Change	-113.0%	-248.13%	-40.72%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-27.00K	-26.00K	-$103.0K
YoY Change	3.85%	4.0%	-103.6%
NET CHANGE
Cash From Operating Activities	-7.000K	-652.0K	$953.0K
Cash From Investing Activities	182.0K	1.508M	-$3.491M
Cash From Financing Activities	-27.00K	-26.00K	-$103.0K
Net Change In Cash	148.0K	830.0K	-$2.641M
YoY Change	-24.49%	-171.61%	-971.62%
FREE CASH FLOW
Cash From Operating Activities	-$7.000K	-$652.0K	$953.0K
Capital Expenditures	$12.00K	$42.00K	$2.188M
Free Cash Flow	-$19.00K	-$694.0K	-$1.235M
YoY Change	-101.28%	-209.46%	-20.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	141000	usd
CY2023Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	31000	usd
CY2022Q1	us-gaap	Customer Deposits Current CustomerDepositsCurrent	24000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1591000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	2260000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	196000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	8819000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3000	usd
CY2022Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	907000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1189000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1159000	usd
CY2022Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	3000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	3837000	usd
CY2022Q1	us-gaap	Liabilities Liabilities	3917000	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15104000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14358000	usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000091668
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q1	sodi	Unrecognized Gains And Losses On Short Term Investments UnrecognizedGainsAndLossesOnShortTermInvestments	917000	usd
CY2022Q1	sodi	Current Portion Mortgage Loan CurrentPortionMortgageLoan	103000	usd
CY2022Q1	sodi	Unrecognized Gains And Losses On Short Term Investments UnrecognizedGainsAndLossesOnShortTermInvestments	930000	usd
CY2022Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2023Q1	sodi	Federal Net Operating Loss Carryforward Expiration2023 FederalNetOperatingLossCarryforwardExpiration2023	7107000000	usd
CY2023Q1	sodi	Federal Net Operating Loss Carryforward Expiration2029 FederalNetOperatingLossCarryforwardExpiration2029	322000000	usd
CY2023	sodi	Concentration Risk Suppliers ConcentrationRiskSuppliers	0.1	pure
CY2022	sodi	Concentration Risk Suppliers ConcentrationRiskSuppliers	0.1	pure
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-02-28
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-04978
CY2023	dei	Entity Registrant Name EntityRegistrantName	SOLITRON DEVICES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	22-1684144
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Sansburys Way
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	West Palm Beach
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33411
CY2023	dei	City Area Code CityAreaCode	561
CY2023	dei	Local Phone Number LocalPhoneNumber	848‑4311
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	13684715	usd
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2083436	shares
CY2023	dei	Auditor Firm AuditorFirmId	206
CY2023	dei	Auditor Name AuditorName	MaloneBailey LLP
CY2023	dei	Auditor Location AuditorLocation	Houston, TX
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4088000	usd
CY2023Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	986000	usd
CY2022Q1	us-gaap	Other Short Term Investments OtherShortTermInvestments	0	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	684000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4926000	usd
CY2023Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	0	usd
CY2022Q1	us-gaap	Construction In Progress Gross ConstructionInProgressGross	609000	usd
CY2023Q1	us-gaap	Assets Assets	15104000	usd
CY2023Q1	sodi	Current Portion Mortgage Loan CurrentPortionMortgageLoan	107000	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	888000	usd
CY2023Q1	sodi	Mortgage Loans Non Current MortgageLoansNonCurrent	2648000	usd
CY2022Q1	sodi	Mortgage Loans Non Current MortgageLoansNonCurrent	2755000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	usd
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	500000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083436	shares
CY2023Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	487827	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2083436	shares
CY2022Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	487827	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	21000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1834000	usd
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1834000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	10824000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9998000	usd
CY2023Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	usd
CY2022Q1	us-gaap	Treasury Stock Value TreasuryStockValue	1412000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11267000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10441000	usd
CY2023	us-gaap	Revenues Revenues	6406000	usd
CY2022	us-gaap	Revenues Revenues	12284000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5005000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7485000	usd
CY2023	us-gaap	Gross Profit GrossProfit	1401000	usd
CY2022	us-gaap	Gross Profit GrossProfit	4799000	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2052000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2507000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-651000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	2292000	usd
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	36000	usd
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	0	usd
CY2023	us-gaap	Interest Expense InterestExpense	108000	usd
CY2022	us-gaap	Interest Expense InterestExpense	103000	usd
CY2023	us-gaap	Dividend Income Operating DividendIncomeOperating	31000	usd
CY2022	us-gaap	Dividend Income Operating DividendIncomeOperating	5000	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	-18000	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	68000	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	886000	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-24000	usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	812000	usd
CY2023	sodi	Scrap Income ScrapIncome	650000	usd
CY2022	sodi	Scrap Income ScrapIncome	441000	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17000	usd
CY2023	us-gaap	Other Income OtherIncome	1477000	usd
CY2022	us-gaap	Other Income OtherIncome	1216000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	826000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	3508000	usd
CY2023	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	0.40
CY2022	sodi	Net Income Per Common Share Basic And Diluted NetIncomePerCommonShareBasicAndDiluted	1.68
CY2023	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083436	shares
CY2022	sodi	Weighted Average Shares Outstanding Basic And Diluted WeightedAverageSharesOutstandingBasicAndDiluted	2083453	shares
CY2022	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	usd
CY2022	sodi	Transfer Agent Adjustment Amount TransferAgentAdjustmentAmount	0	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10441000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	826000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	11267000	usd
CY2023	us-gaap	Profit Loss ProfitLoss	-826000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-3508000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	363000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	264000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	0	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	340000	usd
CY2023	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	868000	usd
CY2022	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	44000	usd
CY2023	sodi	Paycheck Protection Programloanforgiveness PaycheckProtectionProgramloanforgiveness	0	usd
CY2022	sodi	Paycheck Protection Programloanforgiveness PaycheckProtectionProgramloanforgiveness	812000	usd
CY2023	sodi	Accrued Interest Income On Short Term Investments AccruedInterestIncomeOnShortTermInvestments	-26000	usd
CY2022	sodi	Accrued Interest Income On Short Term Investments AccruedInterestIncomeOnShortTermInvestments	0	usd
CY2023	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	0	usd
CY2022	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	17000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-807000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	285000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	155000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-461000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-176000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	10000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-36000	usd
CY2023	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	0	usd
CY2022	us-gaap	Increase Decrease In Operating Liabilities IncreaseDecreaseInOperatingLiabilities	-377000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-9000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-9000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	6000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30000	usd
CY2023	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	7000	usd
CY2022	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	-25000	usd
CY2023	sodi	Accrued Expenses Other Current And Non Current Liabilities AccruedExpensesOtherCurrentAndNonCurrentLiabilities	19000	usd
CY2022	sodi	Accrued Expenses Other Current And Non Current Liabilities AccruedExpensesOtherCurrentAndNonCurrentLiabilities	148000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	953000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3334000	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	971000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	270000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1313000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	660000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	2494000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	1533000	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	0	usd
CY2023	sodi	Expenditures On Construction In Progress ExpendituresOnConstructionInProgress	0	usd
CY2022	sodi	Expenditures On Construction In Progress ExpendituresOnConstructionInProgress	-609000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2188000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4890000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3491000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5889000	usd
CY2023	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	0	usd
CY2022	us-gaap	Proceeds From Loan Originations1 ProceedsFromLoanOriginations1	2940000	usd
CY2023	us-gaap	Payments For Loans PaymentsForLoans	103000	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	82000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-103000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2858000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-2641000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	303000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4088000	usd
CY2023	sodi	Deferred Tax Liability Related To Unrecognized Gains And Losses DeferredTaxLiabilityRelatedToUnrecognizedGainsAndLosses	229000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3785000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1447000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4088000	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
CY2023	us-gaap	Interest Paid InterestPaid	108000	usd
CY2022	us-gaap	Interest Paid InterestPaid	102000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The Company believes COVID-19 had a negative impact on the Company’s bookings in fiscal 2022, and bookings and net sales in fiscal 2023. The Company expects a negative impact to net sales in the first half of fiscal 2024 due to COVID-19 based on bookings being negatively affected in fiscal 2023. </p>
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	986000	usd
CY2023Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	992000	usd
CY2023	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	930000	usd
CY2023	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	27000	usd
CY2023Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1895000	usd
CY2022Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	668000	usd
CY2022	us-gaap	Available For Sale Securities Gross Unrealized Gains AvailableForSaleSecuritiesGrossUnrealizedGains	42000	usd
CY2022	us-gaap	Available For Sale Securities Gross Unrealized Loss AvailableForSaleSecuritiesGrossUnrealizedLoss	26000	usd
CY2022Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	684000	usd
CY2023	sodi	Discription Of Securities DiscriptionOfSecurities	two securities accounted for $1,734,000 of the $1,895,000 balance in marketable securities, and $917,000 of the $930,000 in unrealized gains.
CY2022	sodi	Deferred Tax Liability Related To Unrecognized Gains And Losses DeferredTaxLiabilityRelatedToUnrecognizedGainsAndLosses	0	usd
CY2023Q1	us-gaap	Marketable Securities MarketableSecurities	1895000	usd
CY2022Q1	us-gaap	Marketable Securities MarketableSecurities	684000	usd
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	0	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on the accounts. As of February 28, 2023, and February 28, 2022, all non-interest bearing checking accounts were FDIC insured to a limit of $250,000. Deposits in excess of FDIC insured limits were approximately $129,000 at February 28, 2023 and $3,448,000 at February 28, 2022. With respect to the account receivables, most of the Company’s products are custom made pursuant to contracts with customers whose end-products are sold to the United States Government. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains allowances for potential credit losses. Actual losses and allowances have historically been within management’s expectations. </p>
CY2023Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	129000	usd
CY2022Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	3448000	usd
CY2023	sodi	Financial Statement Estimates FinancialStatementEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and the differences could be material. Such estimates include variable consideration related to revenue recognition, stock-based compensation, depreciable life of property and equipment, accounts receivable allowance, deferred tax valuation allowance, and allowance for inventory obsolescence.</p>
CY2022Q1	sodi	Inventory Net For Material InventoryNetForMaterial	2260000	usd
CY2023	us-gaap	Revenue Recognition Sales Returns RevenueRecognitionSalesReturns	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">2023</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">February 28, </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">2022</p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Beginning Balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">471,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">354,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Accrued Allowances</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">117,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Credits Issued</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Ending Balance</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">471,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">471,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Beginning Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsBeginningBalance	471000	usd
CY2022Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Beginning Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsBeginningBalance	354000	usd
CY2023Q1	sodi	Accrued Allowances AccruedAllowances	0	usd
CY2022Q1	sodi	Accrued Allowances AccruedAllowances	117000	usd
CY2023Q1	sodi	Credits Issued CreditsIssued	0	usd
CY2022Q1	sodi	Credits Issued CreditsIssued	0	usd
CY2023Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Ending Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsEndingBalance	471000	usd
CY2022Q1	sodi	Revenue Recognitions Sales Returns Reserve For Sales Returns Ending Balance RevenueRecognitionsSalesReturnsReserveForSalesReturnsEndingBalance	471000	usd
CY2023Q1	us-gaap	Inventory Gross InventoryGross	7141000000	usd
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	4726000	usd
CY2023Q1	sodi	Inventory Net For Material InventoryNetForMaterial	2415000	usd
CY2022Q1	us-gaap	Inventory Gross InventoryGross	7637000000	usd
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	5377000	usd
CY2023Q1	sodi	Other Inventory Net Of Reserve OtherInventoryNetOfReserve	589000	usd
CY2022Q1	sodi	Other Inventory Net Of Reserve OtherInventoryNetOfReserve	965000	usd
CY2023	sodi	Inventory Consisted InventoryConsisted	100% of the wafer bank inventory consisted of wafers manufactured between calendar year 2018 and 2022
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12049000000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	9860000000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4689000000	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4325000000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	363000000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	264000000	usd
CY2023Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	363000	usd
CY2022Q1	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	375000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	3000	usd
CY2022Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	8000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	20000	usd
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	18000	usd
CY2023Q1	sodi	Return Allowance ReturnAllowance	471000	usd
CY2022Q1	sodi	Return Allowance ReturnAllowance	471000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	50000	usd
CY2022Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	16000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	826000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3508000000	usd
CY2023	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	173000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Current Federal State And Local Tax Expense Benefit CurrentFederalStateAndLocalTaxExpenseBenefit	737000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	55000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.067	pure
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	56000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.016	pure
CY2023	sodi	Permanent Book Tax Differences PermanentBookTaxDifferences	0	usd
CY2023	sodi	Effective Income Tax Rate Permanent Book Tax Difference EffectiveIncomeTaxRatePermanentBookTaxDifference	0	pure
CY2022	sodi	Permanent Book Tax Differences PermanentBookTaxDifferences	-170000	usd
CY2022	sodi	Effective Income Tax Rate Permanent Book Tax Difference EffectiveIncomeTaxRatePermanentBookTaxDifference	-0.048	pure
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-166000000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.201	pure
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-623000000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.178	pure
CY2023	sodi	Rd Credit RDCredit	-50000	usd
CY2023	sodi	Rd Credit Percentage RDCreditPercentage	-0.061	pure
CY2023	sodi	True Up And Adjustments TrueUpAndAdjustments	-12000	usd
CY2023	sodi	True Up And Adjustments Percentage TrueUpAndAdjustmentsPercentage	-0.015	pure
CY2022	sodi	True Up And Adjustments TrueUpAndAdjustments	0	usd
CY2022	sodi	True Up And Adjustments Percentage TrueUpAndAdjustmentsPercentage	0	pure
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0	pure
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000	pure
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	59000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	49000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1198000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	1363000	usd
CY2023Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	119000	usd
CY2022Q1	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2577000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	2065000	usd
CY2023Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	8000	usd
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	14000	usd
CY2023Q1	sodi	Capitalized Rd CapitalizedRD	119000	usd
CY2022Q1	sodi	Capitalized Rd CapitalizedRD	0	usd
CY2023Q1	sodi	Deferred Tax Liabilities Unrealized Gains DeferredTaxLiabilitiesUnrealizedGains	-229000	usd
CY2022Q1	sodi	Deferred Tax Liabilities Unrealized Gains DeferredTaxLiabilitiesUnrealizedGains	0	usd
CY2023Q1	sodi	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	-658000	usd
CY2022Q1	sodi	Deferred Tax Assets Depreciation DeferredTaxAssetsDepreciation	-132000	usd
CY2023Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3193000	usd
CY2022Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3359000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3193000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3359000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2022Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	usd
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3193000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3359000	usd
CY2023	sodi	Cares Act Net Operating Loss Carryforwards Offset Taxable Income Percentage CARESActNetOperatingLossCarryforwardsOffsetTaxableIncomePercentage	1	pure
CY2023	sodi	Recovery Period RecoveryPeriod	P15Y
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	1070000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	780000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	910000	usd
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	620000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	3226000	usd
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	10655000000	usd
CY2023	sodi	Revenue Revenue	6406000000	usd
CY2022	sodi	Revenue Revenue	12284000000	usd
CY2023Q1	us-gaap	Assets Net AssetsNet	3000	usd
CY2022Q1	us-gaap	Assets Net AssetsNet	12000	usd
CY2023	sodi	Description Of Extended Current Lease With Its Landlord DescriptionOfExtendedCurrentLeaseWithItsLandlord	On October 1, 2014, the Company extended its lease with its then landlord, CF EB REO II LLC, for the occupancy and use of a 47,000 square foot facility located at 3301 Electronics Way, West Palm Beach, Florida 33407 (the “Lease”)
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	31555	usd
CY2021Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	340000	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	340000	usd
CY2022Q1	sodi	Operating Lease Right Of Use Assets OperatingLeaseRightOfUseAssets	0	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0	usd
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	0	usd
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	75000	usd
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	457000	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	1000000.0	usd
CY2023	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	16	shares

Files In Submission

Name	View Source	Status
0001654954-23-008351-index-headers.html	Edgar Link	pending
0001654954-23-008351-index.html	Edgar Link	pending
0001654954-23-008351.txt	Edgar Link	pending
0001654954-23-008351-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
sodi-20230228.xsd	Edgar Link	pending
sodi_10k.htm	Edgar Link	pending
sodi_ex231.htm	Edgar Link	pending
sodi_ex31.htm	Edgar Link	pending
sodi_ex32.htm	Edgar Link	pending
sodi-20230228_cal.xml	Edgar Link	unprocessable
sodi-20230228_def.xml	Edgar Link	unprocessable
sodi-20230228_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
sodi-20230228_pre.xml	Edgar Link	unprocessable
sodi_10k_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SODI
SOLITRON DEVICES INC Stock $sodi

2023 Q2 Form 10-K Financial Statement

#000165495423008351 Filed on June 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI SOLITRON DEVICES INC Stock $sodi

2023 Q2 Form 10-K Financial Statement

#000165495423008351 Filed on June 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SODI
SOLITRON DEVICES INC Stock $sodi